Workflow
科学戒烟
icon
Search documents
全球上市近20年,去年国内销售额不足亿元⋯⋯戒烟药在中国为何“水土不服”?
Mei Ri Jing Ji Xin Wen· 2025-06-27 12:00
Core Viewpoint - The article highlights the insufficient public awareness of scientific smoking cessation methods, particularly regarding cessation medications, despite the existence of effective options and guidelines from WHO [1][12]. Group 1: Smoking Cessation Medications - WHO's first clinical treatment guideline for adult smoking cessation identifies three main types of medications: varenicline, nicotine replacement therapy (NRT), and bupropion [1][12]. - Varenicline is a first-line medication with four domestic companies having approved generic versions, yet sales were below 100 million yuan last year [1][12]. - The sales of varenicline in China have not met expectations, with Pfizer's original product experiencing a significant decline due to safety concerns [1][18]. Group 2: Challenges in Smoking Cessation - Nearly 60% of smokers abandon cessation attempts due to withdrawal symptoms, with a success rate of less than 5% for those relying solely on willpower [7][8]. - The understanding of cessation medications among both smokers and healthcare professionals remains limited, contributing to low utilization rates [13][17]. - The lack of awareness and the absence of these medications in insurance coverage are identified as major barriers to effective smoking cessation [20]. Group 3: Market Trends and Opportunities - The retail market for varenicline is projected to grow significantly, with sales expected to reach 48 million yuan in 2024, reflecting a growth rate exceeding 2000% [20][21]. - Online platforms like JD Health report a more than twofold increase in sales of smoking cessation medications, indicating a shift towards digital health solutions [20]. - The market share of companies like Qianyuan Pharmaceutical in the retail sector is notably high, suggesting potential for further expansion in the smoking cessation market [20][21].
专家:只靠意志力戒烟太难,需掌握科学方法
Zhong Guo Xin Wen Wang· 2025-05-31 13:26
"戒烟失败并非意志力不足,而是烟草依赖综合征在作怪。"首都医科大学附属北京朝阳医院烟草依赖治 疗研究室主任梁立荣指出,尼古丁的成瘾性导致烟民在生理和心理上产生高度依赖,戒烟需要专业帮 助,无法仅靠建议。 如何科学戒烟? 贺青华表示,科学戒烟至关重要。近年来,我国吸烟者尝试戒烟的比例逐渐上升,但成功率不足10%。 要提高戒烟成功率,必须配合专业指导。遗憾的是,戒烟药物使用率不足5%,表明许多吸烟者尚未掌 握科学戒烟的方法。 在京东健康第一届戒烟行业论坛上发布的《2025控烟戒烟白皮书》显示,在戒烟手段选择上,有87.1% 的人群尝试通过尼古丁贴片、口香糖等替代品戒烟。超过半数人群使用过药物戒烟,如酒石酸伐尼克兰 片(简称"伐尼克兰片")。 《白皮书》提供了七大戒烟妙招,包括设置戒烟计划、取得亲友帮助与鼓励、加入戒烟社团、扔掉身边 所有和吸烟有关的东西、改变生活方式、食物替代、寻求专业科学的帮助或遵循医嘱使用戒烟药物。 中新网北京5月31日电(赵方园)5月31日是第38个世界无烟日。日前发布的2024中国成人烟草调查结果显 示,中国15岁及以上人群吸烟率为23.2%。 在许多烟民眼中,戒烟是一件需要"钢铁意志力" ...